Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,773 signal articles · 66 in last 24h · 148,348 total before filter · latest 1h ago
66last 24h
973last 7d
109● bullish (7d)
123● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst10
✕ clear all filtersticker: IEXsentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Unpopular Stocks with Open Questions
StockStory31d agoneutral
3 Unpopular Stocks with Open Questions

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

IDEX (IEX) Rides A Strong Narrative, Is It Still Below Fair Value?
Simply Wall St.34d agoneutral
IDEX (IEX) Rides A Strong Narrative, Is It Still Below Fair Value?

IDEX (IEX) has delivered a 47.17% total return over the past year, supported by reported annual revenue of US$3.59b and net income of US$519.5m, which gives investors concrete figures to assess the stock. See our latest analysis for IDEX. Over the past year, IDEX’s share price return has been strong, with a 33.44% year to date gain and a 14.53% 3 month share price return indicating building momentum in addition to its 47.17% 1 year total shareholder return. If you are interested in what else...

1 Mid-Cap Stock to Consider Right Now and 2 We Ignore
StockStory37d agoneutral
1 Mid-Cap Stock to Consider Right Now and 2 We Ignore

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.

Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Mariott International, Merck, Novo Nordisk, Okta, and More
24/7 Wall St.38d agoneutral
Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Mariott International, Merck, Novo Nordisk, Okta, and More

With CPI dropping at 8:30 AM and the Strait of Hormuz near shutdown, Wall Street faces a pivotal morning that could swing stocks sharply in either direction, and analysts at Deutsche Bank, Oppenheimer, Berenberg, and others are already repositioning ahead of the numbers.

IEX Q2 Deep Dive: Data Center and Semiconductor Demand Drive Momentum, Guidance Raised
StockStory50d agoneutral
IEX Q2 Deep Dive: Data Center and Semiconductor Demand Drive Momentum, Guidance Raised

Manufacturing company IDEX (NYSE:IEX) announced better-than-expected revenue in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.

IDEX Q2 Earnings Call Highlights
MarketBeat51d agoneutral
IDEX Q2 Earnings Call Highlights

IDEX (NYSE:IEX) reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted

IDEX Raises Full-Year Outlook After Strong Second-Quarter Results
InvestorsHub52d agoneutral
IDEX Raises Full-Year Outlook After Strong Second-Quarter Results

IDEX Corporation (NYSE:IEX) reported better-than-expected second-quarter earnings and revenue while raising its full-year guidance, sending the industrial technology company’s shares nearly 4% higher in premarket trading on Wednesday. Adjusted earnings came in at $2.

IDEX (IEX) Stock Trades At A Discount On Cash Flow But A Premium On Earnings
Simply Wall St.55d agoneutral
IDEX (IEX) Stock Trades At A Discount On Cash Flow But A Premium On Earnings

IDEX has risen 24.7% year to date, yet its valuation signals are split, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while earnings based multiples lean the other way. The 24.7% year to date gain suggests investors have been willing to pay a richer price for IDEX shares in a relatively short period. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the stock trades at about a 22.8% discount to projected cash flows, while market...